These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
528 related items for PubMed ID: 19808839
21. Role of zoledronic acid in the setting of bone metastases from non-small-cell lung cancer. Langer CJ. Clin Lung Cancer; 2005 Mar; 6(5):314-6. PubMed ID: 15845184 [Abstract] [Full Text] [Related]
22. Zoledronic acid in the treatment of bone metastases from differentiated thyroid carcinoma. Orita Y, Sugitani I, Toda K, Manabe J, Fujimoto Y. Thyroid; 2011 Jan; 21(1):31-5. PubMed ID: 21058881 [Abstract] [Full Text] [Related]
23. Differential effect of doxorubicin and zoledronic acid on intraosseous versus extraosseous breast tumor growth in vivo. Ottewell PD, Deux B, Mönkkönen H, Cross S, Coleman RE, Clezardin P, Holen I. Clin Cancer Res; 2008 Jul 15; 14(14):4658-66. PubMed ID: 18628481 [Abstract] [Full Text] [Related]
24. Bisphosphonates in lung cancer: more than a palliative therapy? Jahanzeb M, Hirsh V. Semin Oncol; 2010 Jun 15; 37 Suppl 1():S45-52. PubMed ID: 20682372 [Abstract] [Full Text] [Related]
25. Zoledronic acid enhances the effect of radiotherapy for bone metastases from renal cell carcinomas: more than a 24-month median follow-up. Takeda N, Isu K, Hiraga H, Shinohara N, Minami A, Kamata H. J Orthop Sci; 2012 Nov 15; 17(6):770-4. PubMed ID: 23053582 [Abstract] [Full Text] [Related]
26. Case 2. Osteonecrosis of the jaws associated with bisphosphonate therapy. Mignogna MD, Fedele S, Lo Russo L, Ciccarelli R, Lo Muzio L. J Clin Oncol; 2006 Mar 20; 24(9):1475-7. PubMed ID: 16549843 [No Abstract] [Full Text] [Related]
27. The use of zoledronic acid in pediatric cancer patients. August KJ, Dalton A, Katzenstein HM, George B, Olson TA, Wasilewski-Masker K, Rapkin LB. Pediatr Blood Cancer; 2011 Apr 20; 56(4):610-4. PubMed ID: 21298747 [Abstract] [Full Text] [Related]
28. Synergistic inhibitory activity of zoledronate and paclitaxel on bone metastasis in nude mice. Lu S, Zhang J, Zhou Z, Liao ML, He WZ, Zhou XY, Li ZM, Xiang JQ, Wang JJ, Chen HQ. Oncol Rep; 2008 Sep 20; 20(3):581-7. PubMed ID: 18695909 [Abstract] [Full Text] [Related]
29. Zoledronic acid in lung cancer with bone metastases: a review. Isla D, Afonso R, Bosch-Barrera J, Martínez N. Expert Rev Anticancer Ther; 2013 Apr 20; 13(4):421-6. PubMed ID: 23560837 [Abstract] [Full Text] [Related]
30. Safety and efficacy of zoledronic acid rapid infusion in lung cancer patients with bone metastases: a single institution experience. Kotteas E, Alamara C, Kiagia M, Pantazopoulos K, Boufas A, Provata A, Charpidou A, Syrigos KN. Anticancer Res; 2008 Apr 20; 28(1B):529-33. PubMed ID: 18383897 [Abstract] [Full Text] [Related]
31. Moving into the future: treatment of bone metastases and beyond. Hortobagyi GN. Cancer Treat Rev; 2005 Apr 20; 31 Suppl 3():9-18. PubMed ID: 16249057 [Abstract] [Full Text] [Related]
35. [A case of effective bisphosphonate therapy for bone metastasis from breast cancer with multiorganic metastases]. Sueyoshi K, Ogura Y, Komori T, Takahashi M, Tian TX, Tatsumi T, Matsuki M, Saika Y, Uesugi Y, Utsunomiya K, Inomata Y, Narabayashi I. Gan To Kagaku Ryoho; 2002 Oct 20; 29(10):1795-9. PubMed ID: 12402432 [Abstract] [Full Text] [Related]
37. The risk of renal impairment in hormone-refractory prostate cancer patients with bone metastases treated with zoledronic acid. Oh WK, Proctor K, Nakabayashi M, Evan C, Tormey LK, Daskivich T, Antràs L, Smith M, Neary MP, Duh MS. Cancer; 2007 Mar 15; 109(6):1090-6. PubMed ID: 17311345 [Abstract] [Full Text] [Related]